Research Article| Volume 3, ISSUE 3, P205-211, July 2012

Effective communication of study results to older participants with prostate cancer: Results of a survey



      We examined attitudes towards, satisfaction with, and costs associated with providing end of study feedback in a group presentation format to older men participating in an observational prostate cancer study. We also aimed to capture the resources required for such a presentation.


      We invited all 186 participants of a longitudinal matched cohort study examining health effects of androgen deprivation therapy in men with prostate cancer who were attending an end-of-study presentation to complete a survey exploring attitudes towards and prior experience with end-of-study results. We also explored the burden communicating end-of-study results might place on study investigators and clinicians.


      Usable surveys were returned by 59 of 70 presentation attendees (84%). Thirty-nine of 59 respondents were study participants while the rest were spouses or guests. Eighty-five percent of respondents agreed/strongly agreed that they had a right to know end-of-study results. Forty-six percent wanted to receive results via email while 45% wanted a group presentation. One-third of respondents had participated in clinical research before; of these, 84% never received study results. Ninety percent of respondents indicated that they were more likely to participate in a study if they knew results would be provided to them. Total resources were under 40 hours and $670 CAD.


      End-of-study results are expected by most study participants. Presentation of aggregate results in a group format may be an effective and efficient way to communicate study results. Including a commitment to an end-of-study presentation may enhance recruitment. Attitudes of non-attendees should be examined in future research.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Shalowitz D.I.
        • Miller F.G.
        Communicating the results of clinical research to participants: attitudes, practices, and future directions.
        PLoS Med. May 13 2008; 5: e91
        • Tu K.
        • Mamdani M.M.
        • Jacka R.M.
        • Forde N.J.
        • Rothwell D.M.
        • Tu J.V.
        The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.
        CMAJ. Mar 4 2003; 168: 553-557
        • Scheuner M.T.
        • Sieverding P.
        • Shekelle P.G.
        Delivery of genomic medicine for common chronic adult diseases: a systematic review.
        JAMA. Mar 19 2008; 299: 1320-1334
        • Ketley D.
        • Woods K.L.
        Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction.
        Lancet. Oct 9 1993; 342: 891-894
        • Jackevicius C.A.
        • Tu J.V.
        • Ross J.S.
        • Ko D.T.
        • Carreon D.
        • Krumholz H.M.
        Use of fibrates in the United States and Canada.
        JAMA. Mar 23 2011; 305: 1217-1224
        • MacNeil S.D.
        • Fernandez C.V.
        Attitudes of research ethics board chairs towards disclosure of research results to participants: results of a national survey.
        J Med Ethics. Sep 2007; 33: 549-553
      1. ([cited]; Available from)
      2. ([cited]; Available from)
        • Shalowitz D.I.
        • Miller F.G.
        Disclosing individual results of clinical research: implications of respect for participants.
        JAMA. Aug 10 2005; 294: 737-740
        • Fernandez C.V.
        • Kodish E.
        • Weijer C.
        Informing study participants of research results: an ethical imperative.
        IRB. May-Jun 2003; 25: 12-19
        • Rigby H.
        • Fernandez C.V.
        Providing research results to study participants: support versus practice of researchers presenting at the American Society of Hematology annual meeting.
        Blood. Aug 15 2005; 106: 1199-1202
        • Sommers M.S.
        Speech perception in older adults: the importance of speech-specific cognitive abilities.
        J Am Geriatr Soc. May 1997; 45: 633-637
        • Reuter-Lorenz P.A.
        • Park D.C.
        Human neuroscience and the aging mind: a new look at old problems.
        J Gerontol B Psychol Sci Soc Sci. Jul 2010; 65: 405-415
        • Partridge A.H.
        • Burstein H.J.
        • Gelman R.S.
        • Marcom P.K.
        • Winer E.P.
        Do patients participating in clinical trials want to know study results?.
        J Natl Cancer Inst. Mar 19 2003; 95: 491-492
        • Miller F.A.
        • Christensen R.
        • Giacomini M.
        • Robert J.S.
        Duty to disclose what? Querying the putative obligation to return research results to participants.
        J Med Ethics. Mar 2008; 34: 210-213
        • Partridge A.H.
        • Wong J.S.
        • Knudsen K.
        • Gelman R.
        • Sampson E.
        • Gadd M.
        • et al.
        Offering participants results of a clinical trial: sharing results of a negative study.
        Lancet. Mar 12–18 2005; 365: 963-964
        • Fernandez C.V.
        • Kodish E.
        • Taweel S.
        • Shurin S.
        • Weijer C.
        Disclosure of the right of research participants to receive research results: an analysis of consent forms in the Children's Oncology Group.
        Cancer. Jun 1 2003; 97: 2904-2909
        • Di Blasi Z.
        • Kaptchuk T.J.
        • Weinman J.
        • Kleijnen J.
        Informing participants of allocation to placebo at trial closure: postal survey.
        BMJ. Dec 7 2002; 325: 1329
        • Dixon-Woods M.
        • Jackson C.
        • Windridge K.C.
        • Kenyon S.
        Receiving a summary of the results of a trial: qualitative study of participants' views.
        BMJ. Jan 28 2006; 332: 206-210
        • Fernandez C.V.
        • Kodish E.
        • Shurin S.
        • Weijer C.
        Offering to return results to research participants: attitudes and needs of principal investigators in the Children's Oncology Group.
        J Pediatr Hematol Oncol. Sep 2003; 25: 704-708
        • Avins A.L.
        • Bent S.
        • Padula A.
        • Staccone S.
        • Badua E.
        • Goldberg H.
        Initial experience with a group presentation of study results to research participants.
        Trials. 2008; 9: 16
        • Buchwald H.
        • Fitch L.L.
        • Matts J.P.
        • Johnson J.W.
        • Hansen B.J.
        • Stuenkel M.R.
        • et al.
        Perception of quality of life before and after disclosure of trial results: a report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
        Control Clin Trials. Dec 1993; 14: 500-510
        • Snowdon C.
        • Garcia J.
        • Elbourne D.
        Reactions of participants to the results of a randomised controlled trial: exploratory study.
        BMJ. Jul 4 1998; 317: 21-26
        • Fernandez C.V.
        • Skedgel C.
        • Weijer C.
        Considerations and costs of disclosing study findings to research participants.
        CMAJ. Apr 27 2004; 170: 1417-1419
        • Alibhai S.M.H.
        • Breunis H.
        • Timilshina N.
        • Johnston C.
        • Tomlinson G.
        • Tannock I.
        • et al.
        Impact of androgen-deprivation therapy on physical function and quality of life in men with non-metastatic prostate cancer.
        J Clin Oncol. 2010; 28: 5038-5045
        • Alibhai S.M.H.
        • Breunis H.
        • Timilshina N.
        • Marzouk S.
        • Stewart D.
        • Tannock I.
        • et al.
        Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer.
        J Clin Oncol. Dec 1 2010; 38: 5030-5037